Estrogen News and Research

Latest Estrogen News and Research

Acrylamide is carcinogenic and may increase the risk of breast cancer

Acrylamide is a chemical formed when frying, roasting, grilling or baking carbohydrate-rich foods at temperatures above 120°C.

10 Jan 2008

FDA says claims about benefits of bio-identical hormone replacement therapy are false and misleading

Health officials in the United States have issued a warning regarding so-called "bio-identical" hormone therapy (BHRT).

10 Jan 2008

People whose index finger is shorter than their ring finger are at higher risk of osteoarthritis

A study of more than 2,000 people, published in the journal Arthritis and Rheumatism, suggests that people whose index finger is shorter than their ring finger are up to twice as likely to suffer from the condition, which is the most common form of arthritis.

7 Jan 2008

The risk of osteoarthritis and index to ring finger length ratio

Index to ring finger length ratio (2D:4D) is a trait known for its sexual differences.

3 Jan 2008

Hormone therapy in younger menopausal women

Could hormone therapy, when begun near the onset of menopause, prevent or delay the onset of atherosclerosis, more commonly called hardening of the arteries.

3 Jan 2008

No excess cardiovascular risk from HRT for most patients

An American Association of Clinical Endocrinologists (AACE) analysis of several studies monitoring the impact of Hormone Replacement Therapy (HRT) shows young women in early menopause may not only have no increased cardiovascular risk from the therapy, but may indeed show benefit in the future.

3 Jan 2008

Study shows that antiangiogenic agent delays progression of advanced breast cancer

The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine.

28 Dec 2007

Chemotherapy and tamoxifen reduce risk of second breast cancer

Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute.

28 Dec 2007

$Osteoporosis in women - previous vertebral fracture equals increased long-term risk for new fracture$

Osteoporosis in women - previous vertebral fracture equals increased long-term risk for new fracture

Over a 15 year period, women with low bone mineral density and a previous vertebral fracture had an increased risk of a new vertebral fracture compared to women with normal bone mineral density and no previous fracture, according to a study in the December 19 issue of JAMA.

20 Dec 2007

Effectiveness and risks of six bisphosphonates for osteoporosis

Many medications reduce the risk of bone fractures in people with osteoporosis, but the most commonly used drugs - bisphosphonates - have not been proven more effective than alternatives, according to a new report funded by the Agency for Healthcare Research and Quality (AHRQ), part of the U.S. Department of Health and Human Services.

18 Dec 2007

Survival shortened when estrogen or progesterone receptor negative breast cancer spreads to the brain

Two studies from Mayo Clinic's site in Jacksonville, Fla., of women whose breast cancer spread to their brain, have found that women whose tumors do not have estrogen or progesterone receptors have the worst overall outcomes.

17 Dec 2007

High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer

High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.

14 Dec 2007

Early results show promise in reducing side effects from anastrozole

A common osteoporosis drug can shield women against the loss of bone mineral density - a side effect of the drug anastrozole which is taken to prevent breast cancer in the IBIS-2 study - according to new data presented at the San Antonio Breast Cancer Symposium.

14 Dec 2007

Relationship of female sex hormones to mood states and disorders merits better research

Countless movies and TV shows make light of women's so-called “moodiness”, often jokingly attributing it to their menstrual cycle or, conversely, to menopause.

13 Dec 2007

Scientists develop new drug to outflank cancer resistance

A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.

12 Dec 2007

Novel technique using computer modeling identifies potential side effects of pharmaceuticals

Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.

12 Dec 2007

Study shows how mutations in the BRCA1 gene lead to breast cancer

An international team of researchers led by Columbia University Medical Center's Herbert Irving Comprehensive Cancer Center and Sweden's Lund University has, for the first time, revealed how mutations in the BRCA1 gene lead to breast cancer.

10 Dec 2007

Most baby-food manufacturers using toxic chemical in packaging

An environmental organization in the U.S. says that cans containing liquid infant formula and sold in North America, contain the toxic chemical Bisphenol A (BPA).

6 Dec 2007

Anorexia begins in the womb

New research is suggesting that a male twin who shares the womb with a female twin is almost as likely as twin girls to be diagnosed with anorexia.

5 Dec 2007

Bionovo describes a new class of therapeutic compounds

Bionovo, Inc. has announced the publication of a groundbreaking paper in the journal Molecular and Cellular Endocrinology covering the isolation, identification and description of a pure chemical compound, liquiritigenin, which represents a new class of therapeutic compounds showing promise for the safe treatment of menopausal symptoms.

2 Dec 2007

Estrogen News and Research

Latest Estrogen News and Research

Acrylamide is carcinogenic and may increase the risk of breast cancer

FDA says claims about benefits of bio-identical hormone replacement therapy are false and misleading

People whose index finger is shorter than their ring finger are at higher risk of osteoarthritis

The risk of osteoarthritis and index to ring finger length ratio

Hormone therapy in younger menopausal women

No excess cardiovascular risk from HRT for most patients

Study shows that antiangiogenic agent delays progression of advanced breast cancer

Chemotherapy and tamoxifen reduce risk of second breast cancer

Osteoporosis in women - previous vertebral fracture equals increased long-term risk for new fracture

Effectiveness and risks of six bisphosphonates for osteoporosis

Survival shortened when estrogen or progesterone receptor negative breast cancer spreads to the brain

High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer

Early results show promise in reducing side effects from anastrozole

Relationship of female sex hormones to mood states and disorders merits better research

Scientists develop new drug to outflank cancer resistance

Novel technique using computer modeling identifies potential side effects of pharmaceuticals

Study shows how mutations in the BRCA1 gene lead to breast cancer

Most baby-food manufacturers using toxic chemical in packaging

Anorexia begins in the womb

Bionovo describes a new class of therapeutic compounds

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Estrogen News and Research

Latest Estrogen News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in